Recombinant Protein Market is Estimated to Witness High Growth Owing to Opportunity of Wide Application Areas Across Healthcare Industry

Recombinant Protein Market


 Recombinant protein products are artificially created proteins produced by various biological means such as gene cloning and protein engineering. They find wide application across various therapeutic areas like oncology, hematology, endocrinology, and others due to their advantages over naturally occurring proteins for disease treatment. Major therapeutic recombinant proteins available in the market include insulin, growth hormones, clotting factors, interferons, interleukins, colony stimulating factors, and others. Some key features of recombinant proteins include large-scale production, consistency in quality and purity, precise molecular structure and function, and improved safety profile.


The global recombinant protein market is estimated to be valued at US$ 3131.37 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The wide application areas of recombinant proteins across the healthcare industry present a major market opportunity. Various diseases like diabetes, cancer, hemophilia, hepatitis, and others can be effectively managed through recombinant protein therapeutics. The growing geriatric population globally which is more prone to chronic diseases will propel the demand for accessible and effective treatment options like recombinant proteins. Moreover, the introduction of new recombinant protein drugs in the pipeline and their approval will further expand the application areas and drive the market growth over the forecast period.

Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate. High capital requirements for R&D and manufacturing pose barriers. However, biologics and biosimilars have lower entry barriers.
Bargaining power of buyers: The bargaining power of buyers is high due to the presence of many global players. Buyers can negotiate on price and quality.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are many suppliers for raw materials. However, suppliers of key materials may exploit their positions.
Threat of new substitutes: The threat of new substitutes is high. Many new biologics and biosimilars are entering the market as substitutes.
Competitive rivalry: Competition is high amongst existing players due to their large product portfolios and focus on R&D.

SWOT Analysis
Strength: High demand for therapies to treat cancers and chronic diseases. Growing biologics market globally.
Weakness: High capital requirements. Stringent regulatory norms. Supply chain challenges.
Opportunity: Emerging markets growth. Increasing healthcare spending globally. biosimilars growth.
Threats: Price control regulations. Patent cliffs of major drugs. Reimbursement issues.

Key Takeaways

The Global Recombinant Protein Market Share is expected to witness high growth during the forecast period of 2023 to 2030. The market size for 2024 is estimated to be US$ 3131.37 Mn, registering a CAGR of 7.3%.

Regional analysis: North America currently dominates the market due to advanced healthcare infrastructure and high adoption of new therapies. The Asia Pacific region is expected to grow at the fastest pace owing to growing economies, increasing healthcare spending, and rising prevalence of chronic diseases.

Key players related content: Key players operating in the recombinant protein market are Merck KGaA, Allergan plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Bausch & Lomb, Inotek, Jadran-galenski laboratorij d.d. JGL d.d, Aerie Pharmaceutical and Mylan N.V. Merck KGaA leads the market with its strong portfolio of recombinant proteins for various therapies.

For more details on the report, Read-https://www.pressreleasebulletin.com/recombinant-protein-market-trends-size-and-share-analysis/

Comments

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Global Synthetic Biology Market Analysis: Size and Share